GlobeNewsWire · OCS · October 19, 2026

Oculis lýkur slembiröðun í PREDICT-1 skráningarrannsókninni á Licaminlimab við TNFR1-miðluðum augnþurrki

Get the app for more

Explore stock news, insights and company research.